NCT07444697 "Erectile Function After PCI in MI and Non-MI Patients"
| NCT ID | NCT07444697 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kırıkkale University |
| Condition | Erectile Disfunction |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-01-15 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-01-15 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to assess changes in patients' erectile function after percutaneous coronary intervention (PCI) using a standard IIEF (International Index of Erectile Function) questionnaire at 1, 3, and 6 months post-PCI. By doing this, we try to compare patients' responses to PCI after having a heart attack and stable angina to see the real effect of myocardial infarction on erectile function status in the long term by comparing it with a very similar group.
Eligibility Criteria
Inclusion Criteria * Male patients aged 30-75 years * Undergoing successful percutaneous coronary intervention (PCI) for one of the following: * Acute myocardial infarction (Group 1) * Stable angina (Group 2) * Hemodynamically stable after the PCI procedure * Survival of the index hospitalization * Ability to provide written informed consent * Sexually active within the 3 months prior to enrollment * Willingness and ability to complete follow-up visits and questionnaires at: * Baseline (post-PCI recovery) * 3 months * 6 months Exclusion Criteria * Known malignancy (active or recently treated) * Neurological disorders affecting erectile function, including: * Spinal cord injury * Multiple sclerosis * Parkinson's disease * Uncontrolled diabetes mellitus (HbA1c \> 9%) * Presence of more than two chronic systemic diseases, such as: * Severe renal disease * Severe hepatic disease * Severe pulmonary disease * Polypharmacy, defined as chronic use of more than three daily medications * Absence of sexual activity or lack of a sexual partner * Refusal or inability to provide informed consent or complete study questionnaires * Severe psychiatric illness interfering with study participation * Endocrine disorders, including: * Untreated hypogonadism * Thyroid disease * Major post-PCI complications preventing participation, including: * Reinfarction * Stroke * Heart failure
Contact & Investigator
Timucin Sipal, Assistan Prof
PRINCIPAL INVESTIGATOR
Kirikkale Univerity faculty of medicine department of Urology
Frequently Asked Questions
Who can join the NCT07444697 clinical trial?
This trial is open to male participants only, aged 30 Years or older, up to 75 Years, studying Erectile Disfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07444697 currently recruiting?
Yes, NCT07444697 is actively recruiting participants. Contact the research team at drtimucin@hotmail.com for enrollment information.
Where is the NCT07444697 trial being conducted?
This trial is being conducted at Kirikkale, Turkey (Türkiye).
Who is sponsoring the NCT07444697 clinical trial?
NCT07444697 is sponsored by Kırıkkale University. The principal investigator is Timucin Sipal, Assistan Prof at Kirikkale Univerity faculty of medicine department of Urology. The trial plans to enroll 100 participants.